Our latest thinking

Where does India’s opportunity lie in pharma’s new architecture?

Pharma shifts to AI-led platform models, integrating discovery, data and manufacturing—positioning India as a key player in global biopharma innovation.

Onwards and upwards: A positive outlook for private credit in India

Private Credit In India: Discover how the private credit market has progressed in India. Explore the growth of private credit fund & alternative lending.

AI and Cybersecurity: Powering the next frontier of business resilience

Learn how artificial intelligence is reshaping cybersecurity, addressing emerging risks like deepfakes while helping organizations strengthen protection, response, and overall resilience.


    Explore insights and services for your C-suite role

    We know the imperatives of transformation and sustainable growth place varying demands on leaders across the C-suite, so we’ve curated our most actionable insights and relevant services for each leadership role.




    Featured press releases

    Private credit market records investments of US$3.4 Billion in H2 2025: EY Private Credit Report

    Private credit investments in India reached US$3.4bn in H2 2025, with CY 2025 deployment at US$12.4bn. Real estate, healthcare and refinancing drove growth.

    18 Feb 2026 | EY India

    AI-Powered Platforms for Discovery, R&D and Connected Manufacturing to Drive Indian Biopharma’s Next Growth Phase: EY-Parthenon report at BioAsia 2026

    Explore how AI-enabled discovery, R&D and connected manufacturing platforms will drive Indian biopharma’s next growth phase in the EY-Parthenon BioAsia 2026 report.

    17 Feb 2026 | Hyderabad, India | EY India